| Literature DB >> 28228282 |
Bertrand Calippe1, Sebastien Augustin1, Fanny Beguier1, Hugo Charles-Messance1, Lucie Poupel2, Jean-Baptiste Conart1, Shulong J Hu1, Sophie Lavalette1, Alexandre Fauvet1, Julie Rayes3, Olivier Levy1, William Raoul1, Catherine Fitting4, Thomas Denèfle5, Matthew C Pickering6, Claire Harris7, Sylvie Jorieux8, Patrick M Sullivan9, José-Alain Sahel1, Philippe Karoyan5, Przemyslaw Sapieha10, Xavier Guillonneau1, Emmanuel L Gautier2, Florian Sennlaub11.
Abstract
Variants of the CFH gene, encoding complement factor H (CFH), show strong association with age-related macular degeneration (AMD), a major cause of blindness. Here, we used murine models of AMD to examine the contribution of CFH to disease etiology. Cfh deletion protected the mice from the pathogenic subretinal accumulation of mononuclear phagocytes (MP) that characterize AMD and showed accelerated resolution of inflammation. MP persistence arose secondary to binding of CFH to CD11b, which obstructed the homeostatic elimination of MPs from the subretinal space mediated by thrombospsondin-1 (TSP-1) activation of CD47. The AMD-associated CFH(H402) variant markedly increased this inhibitory effect on microglial cells, supporting a causal link to disease etiology. This mechanism is not restricted to the eye, as similar results were observed in a model of acute sterile peritonitis. Pharmacological activation of CD47 accelerated resolution of both subretinal and peritoneal inflammation, with implications for the treatment of chronic inflammatory disease.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28228282 DOI: 10.1016/j.immuni.2017.01.006
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745